New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Mechanisms behind aggressive cancer metastases uncovered

Mechanisms behind aggressive cancer metastases uncovered

by Angelika Jacobs,University of BaselThe molecular basis for metastatic colonization of distant organs remains incompletely understood. This study uncovers a critical role for NAD+metabol
World medicine December 07,2023
Mechanisms behind aggressive cancer metastases uncovered

Mechanisms behind aggressive cancer metastases uncovered

by Angelika Jacobs,University of BaselThe molecular basis for metastatic colonization of distant organs remains incompletely understood. This study uncovers a critical role for NAD+metabol
World medicine December 07,2023
Potential target for reversing drug resistance in ovarian cancer identified

Potential target for reversing drug resistance in ovarian cancer identified

by Cat Diamond,Xi'an jiaotong-Liverpool UniversityCisplatin crystals, which is a platinum compound, and used as a chemotherapy drug. Credit: Larry Ostby, National Cancer Institute - Public d
World medicine December 07,2023
Potential target for reversing drug resistance in ovarian cancer identified

Potential target for reversing drug resistance in ovarian cancer identified

by Cat Diamond,Xi'an jiaotong-Liverpool UniversityCisplatin crystals, which is a platinum compound, and used as a chemotherapy drug. Credit: Larry Ostby, National Cancer Institute - Public d
World medicine December 07,2023
Discovering targetable vulnerabilities in endocrine therapy-resistant breast cancer

Discovering targetable vulnerabilities in endocrine therapy-resistant breast cancer

by Ana María Rodríguez,Baylor College of MedicineCredit: Pixabay/CC0 Public DomainWhen it comes to cancer, developing resistance to therapy and metastasis, the ability to spread outside the orga
World medicine December 07,2023
Discovering targetable vulnerabilities in endocrine therapy-resistant breast cancer

Discovering targetable vulnerabilities in endocrine therapy-resistant breast cancer

by Ana María Rodríguez,Baylor College of MedicineCredit: Pixabay/CC0 Public DomainWhen it comes to cancer, developing resistance to therapy and metastasis, the ability to spread outside the orga
World medicine December 07,2023
Glioblastoma found to hijack cognitive neural networks with thrombospondin-1

Glioblastoma found to hijack cognitive neural networks with thrombospondin-1

by Justin Jackson , Medical XpressExperimental workflow. a, Schematic of study workflow. In human participants with dominant hemisphere gliomas, we applied subcortical high density electrocorticograph
World medicine December 07,2023
Glioblastoma found to hijack cognitive neural networks with thrombospondin-1

Glioblastoma found to hijack cognitive neural networks with thrombospondin-1

by Justin Jackson , Medical XpressExperimental workflow. a, Schematic of study workflow. In human participants with dominant hemisphere gliomas, we applied subcortical high density electrocorticograph
World medicine December 07,2023
Patients with IBD found to be at higher risk of lymphoma

Patients with IBD found to be at higher risk of lymphoma

byKarolinska InstitutetCredit: Pixabay/CC0 Public DomainThe risk of developing lymphoma is slightly elevated in inflammatory bowel disease (IBD) and has increased in recent years in patients wit
World medicine December 07,2023
Patients with IBD found to be at higher risk of lymphoma

Patients with IBD found to be at higher risk of lymphoma

byKarolinska InstitutetCredit: Pixabay/CC0 Public DomainThe risk of developing lymphoma is slightly elevated in inflammatory bowel disease (IBD) and has increased in recent years in patients wit
World medicine December 07,2023
FTD-TPI plus bevacizumab found to increase survival in refractory advanced CRC

FTD-TPI plus bevacizumab found to increase survival in refractory advanced CRC

by Elana GotkineTreatment with trifluridine-tipiracil (FTD-TPI) plus bevacizumab yields longer overall survival than FTD-TPI alone among patients with refractory metastatic colorectal cancer, accordin
World medicine December 07,2023
FTD-TPI plus bevacizumab found to increase survival in refractory advanced CRC

FTD-TPI plus bevacizumab found to increase survival in refractory advanced CRC

by Elana GotkineTreatment with trifluridine-tipiracil (FTD-TPI) plus bevacizumab yields longer overall survival than FTD-TPI alone among patients with refractory metastatic colorectal cancer, accordin
World medicine December 07,2023
12 months of anticoagulation found to improve outcomes in cancer patients with minor blood clots

12 months of anticoagulation found to improve outcomes in cancer patients with minor blood clots

byEuropean Society of CardiologyCredit: Pixabay/CC0 Public DomainTwelve months of edoxaban is superior to three months for the reduction of thrombotic events in patients with cancer and distal d
World medicine December 07,2023
12 months of anticoagulation found to improve outcomes in cancer patients with minor blood clots

12 months of anticoagulation found to improve outcomes in cancer patients with minor blood clots

byEuropean Society of CardiologyCredit: Pixabay/CC0 Public DomainTwelve months of edoxaban is superior to three months for the reduction of thrombotic events in patients with cancer and distal d
World medicine December 07,2023
Metformin's role in preventing metabolic syndrome during androgen deprivation therapy

Metformin's role in preventing metabolic syndrome during androgen deprivation therapy

by Impact Journals LLCVariable changes in phosphorylation of S6 kinase 1 was observed in both cohorts. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28458A new research paper titled &q
World medicine December 07,2023
Metformin's role in preventing metabolic syndrome during androgen deprivation therapy

Metformin's role in preventing metabolic syndrome during androgen deprivation therapy

by Impact Journals LLCVariable changes in phosphorylation of S6 kinase 1 was observed in both cohorts. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28458A new research paper titled &q
World medicine December 07,2023
Open-analysis platform for pediatric brain tumors provides robust data resource for childhood cancer research

Open-analysis platform for pediatric brain tumors provides robust data resource for childhood cancer research

byChildren's Hospital of PhiladelphiaOverview of the OpenPBTA Project.A, The Children’s Brain Tumor Network and the Pacific Pediatric Neuro-Oncology Consortium collected tumor samples from 9
World medicine December 07,2023
Open-analysis platform for pediatric brain tumors provides robust data resource for childhood cancer research

Open-analysis platform for pediatric brain tumors provides robust data resource for childhood cancer research

byChildren's Hospital of PhiladelphiaOverview of the OpenPBTA Project.A, The Children’s Brain Tumor Network and the Pacific Pediatric Neuro-Oncology Consortium collected tumor samples from 9
World medicine December 07,2023
Fertility may decline early in women treated as children for Hodgkin lymphoma; more successfully pregnant at younger age

Fertility may decline early in women treated as children for Hodgkin lymphoma; more successfully pregnant at younger age

byEuropean Society of Human Reproduction and EmbryologyCredit: Unsplash/CC0 Public DomainWomen treated for childhood Hodgkin lymphoma may face declining fertility at a younger age, according to
World medicine December 07,2023
Fertility may decline early in women treated as children for Hodgkin lymphoma; more successfully pregnant at younger age

Fertility may decline early in women treated as children for Hodgkin lymphoma; more successfully pregnant at younger age

byEuropean Society of Human Reproduction and EmbryologyCredit: Unsplash/CC0 Public DomainWomen treated for childhood Hodgkin lymphoma may face declining fertility at a younger age, according to
World medicine December 07,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com